Innovative thin-film, transdermal, and enteric-coated tablet technologies are developed to enhance drug delivery, bioavailability, and patient compliance for treating neurodegenerative, autoimmune, and chronic diseases. The focus is on creating patient-centric therapeutics that aim to improve health outcomes.